A 38-year-old woman in Brooklyn opens her insurance statement and finds that her health plan covers two diagnostic cycles, not the in vitro fertilization that follows. She prices the IVF program at a Manhattan clinic at roughly $25,000. The same program at Assuta in Tel Aviv runs $6,000 to $8,000. Three years ago, she would have shopped for flights. In 2026 her Manhattan clinic offers her a 36-month installment plan at the consult, with the first payment due after the first cycle.

The price gap is unchanged. The decision tree she walks out with has quietly moved, and with it the demand curve facing every Israeli clinic on the inbound side of this market.

The country’s pricing advantage over the United States, in IVF, dental work, and aesthetic surgery, is bigger than ever, and the supply-side infrastructure that delivers it has only deepened. What has changed sits on the US demand side. It is a payment plan.

Israel’s Medical Tourism Pricing Edge, Quantified

The Israel Ministry of Health records roughly 30,000 medical tourists arriving in the country each year and an estimated $100 million in annual revenue tied to the inbound flow. The pricing edge sits in the procedures Israel has built a reputation for. It is not subtle.

Israel21c reporting priced dental implant work for US patients at $24,000 over a 12-month course in the United States against $11,000 in Israel in a compressed time window, with dental tourists saving up to 60% on implants overall. Medical procedures in Israel often run 30% to 50% less than the same care in the United States by the same reporting. A full IVF program in Israel costs $6,000 to $8,000, a fraction of comparable US clinic pricing.

The hospital base behind those numbers is concentrated, with Israel’s medical tourism flowing through........

© The Times of Israel (Blogs)